Search research articles
Contact Us
Filters
Showing results (501-510 of 538) with videos related to
Page
of 54
Sort By:
Dementia and Geriatric Cognitive Disorders
|
March 2, 2012
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease
Maria Eriksdotter-Jönhagen, Bengt Linderoth, Göran Lind, et al.
Alzheimer'S Research & Therapy
|
October 26, 2018
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
Alzheimer'S Research & Therapy
|
May 24, 2025
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC
Kristian S Frederiksen, Mercé Boada, Bruno Dubois, et al.
Nature Reviews. Neurology
|
December 17, 2014
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleó, Enrica Cavedo, Lucilla Parnetti, et al.
Lancet (London, England)
|
April 25, 2006
Mild cognitive impairment
Serge Gauthier, Barry Reisberg, Michael Zaudig, et al.
Brain Communications
|
September 8, 2023
Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities
Makrina Daniilidou, Francesca Eroli, Vilma Alanko, et al.
Cell Research
|
November 18, 2021
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Keliang Pang, Richeng Jiang, Wei Zhang, et al.
The Lancet. Neurology
|
December 14, 2016
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease
Sandar Aye, Gunilla Johansson, Christoph Hock, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2021
A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project
Anders Wimo, Mark Belger, Jaka Bon, et al.
Page
of 54
Search research articles
Search
Showing results (501-510 of 538) with videos related to
Sort By:
Page
of 54
Dementia and Geriatric Cognitive Disorders
|
March 2, 2012
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease
Maria Eriksdotter-Jönhagen, Bengt Linderoth, Göran Lind, et al.
Alzheimer'S Research & Therapy
|
October 26, 2018
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
Alzheimer'S Research & Therapy
|
May 24, 2025
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC
Kristian S Frederiksen, Mercé Boada, Bruno Dubois, et al.
Nature Reviews. Neurology
|
December 17, 2014
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleó, Enrica Cavedo, Lucilla Parnetti, et al.
Lancet (London, England)
|
April 25, 2006
Mild cognitive impairment
Serge Gauthier, Barry Reisberg, Michael Zaudig, et al.
Brain Communications
|
September 8, 2023
Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities
Makrina Daniilidou, Francesca Eroli, Vilma Alanko, et al.
Cell Research
|
November 18, 2021
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Keliang Pang, Richeng Jiang, Wei Zhang, et al.
The Lancet. Neurology
|
December 14, 2016
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
Petr Novak, Reinhold Schmidt, Eva Kontsekova, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease
Sandar Aye, Gunilla Johansson, Christoph Hock, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2021
A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project
Anders Wimo, Mark Belger, Jaka Bon, et al.
Page
of 54